We are live on ! Find out more
APEN

Apollo Endosurgery, Inc.

Delisted

APEN was delisted on the 3rd of April, 2023.

0 hedge funds and large institutions have $0 invested in Apollo Endosurgery, Inc. in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 89 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 890 (-89)

100% less funds holding in top 10

Funds holding in top 10: 90 (-9)

100% less capital invested

Capital invested by funds: $442M → $0 (-$442M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 89

Holders
Holders Change
-89
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
-9
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
89
Calls
Puts
Net Calls
Net Calls Change

APEN Hedge Fund Activity: Q2 2023 in Review

0 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q2 2023, worth a combined $0 — down 100% from $442M a quarter earlier.

Sellers outnumbered buyers: 89 funds closed out of APEN and 0 opened new positions — a net loss of 89 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was CPMG Inc, exiting entirely with an estimated $61.3M sold.

  • 0 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q2 2023, down from 89 in Q1 2023.
  • Funds reported $0 of Apollo Endosurgery, Inc. stock for Q2 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Apollo Endosurgery, Inc. positions in Q2 2023 and 89 closed out, a net change of -89 holders.
  • The largest Apollo Endosurgery, Inc. seller in Q2 2023 was CPMG Inc, an estimated $61.3M sold.

Based on aggregated 13F filings for Q2 2023.